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BACKGROUND: For the past decades, developing countries have received considerable support to fight 
infectious illnesses in their homelands. This global effort has tremendously reduced case fatality rates 
associated with illnesses such as HIV/AIDS, tuberculosis and malaria in many countries. However, this 
information is still missing in some developing countries, hindering international effort for control 
programs; we designed this study in effort to close this gap.  
METHODS: Data on 23,487 inpatients from Kinshasa hospitals were gathered and analyzed using 
EpiData and SPSS. Major illnesses affecting inpatients were identified; mortality and case fatality rates 
associated with each such illness were estimated. Case fatality rates associated with each illness were 
compared between consecutive years. Socio demographic and economic factors associated with mortality 
due to HIV/AIDS, TB and malaria were investigated using logistic regression. 
RESULTS: The outstanding findings were that case fatality rates associated with major illnesses were 
relatively higher in 2008 than in the previous year; inpatients hospitalized for HIV/AIDS, TB and 
malaria in 2008 were more likely to die than those hospitalized in the previous year. Low socioeconomic 
status inpatients hospitalized for malaria, HIV/AIDS or TB were more likely to die than high 
socioeconomic status inpatients (AOR 0.29, 95% CI 0.22–0.40; AOR 0.20, 95%CI0.12–0.33; AOR 0.33, 
95%CI 0.21–0.53), even though both groups presumably had access to free life-saving treatment and 
care.  
CONCLUSION: These results indicate that while improvement in health indicators greatly depends on 
funds availability and sustainability, these alone might not be enough in resource poor developing 
countries. Other factors, i.e., population SES also need to be addressed before needed changes may 
occur.  
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The burden of infectious diseases has been 
continuously ruthless on developing country 
populations (1, 2), probably due to meagre 
government spending in the health sectors (3, 4) 
and the lack of expertise and data for planning and 
formulating effective health Policies (5). 
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Today, however, these claims are no longer 
enough to justify high mortality and case fatality 
rates (CFR) related to infectious diseases, 
particularly to HIV/AIDS, TB and malaria in 
developing countries (2, 6, 7, 8). This is because 
for the past decades, these countries receive, 
through international partnership, considerable 
and sustainable support to fight major infectious 
diseases in their homelands (8). The Global Fund 
to Fight AIDS, TB and Malaria (GFATM) for 
instance, has been attracting and disbursing 
additional funds to prevent and treat HIV/AIDS, 
tuberculosis and malaria in endemic regions for 
many years. From its launching in 2002 by the G8 
to 2010, GFATM had committed more than 
US$22 billion in 150 countries (9, 10). Allegedly, 
every population in these countries has access not 
only to free life-saving antiretroviral treatment 
(ART) and TB drugs and care, but also to large-
scale prevention programs against the three 
pandemics (9). The US Center for Diseases 
Control (CDC), through its global infectious 
diseases strategies, has been very active in 
endemic areas for many years, bringing in experts, 
logistics and funds to fight infectious diseases (11, 
12). Adding to that is the implication of 
organizations such as the Canadian International 
Development Agency (CIDA), UNICEF and 
Population Services International (PSI), to name 
but a few, in strengthening health sectors in 
developing countries (13).  
This international effort has brought 
tremendous improvement on health indicators in 
many developing countries, particularly on HIV, 
TB and malaria (11, 14, 15). In his address at the 
22
nd
 board meeting in Sofia, the Global Fund’s 
Executive Director, made it clear that the scaling 
up of malaria interventions was reducing 
childhood mortality, and that the number of new 
cases of HIV/AIDS had fallen globally by more 
than 20% since 1997. TB-related mortality went 
down by more than a third from 1990 (9). While 
these statements bring new hope to our battle 
against infectious diseases, data from Democratic 
Republic of Congo (DRC) are indicating that the 
majority of deaths in this country are still due to 
infectious diseases (16), particularly malaria, 
HIV/AIDS and TB; seemingly because of severe 
poverty among populations and limited access to 
health care facilities (17). Reportedly (18), 
populations with lower socioeconomic status 
(LSES) have limited access to free malaria 
protection tools than those with higher 
socioeconomic status (HSES), thus resulting in 
higher childhood mortality among rural poor 
populations compared to urban dwellers (13, 16). 
While these data are of great relevance for policy 
making, they would have been of even more 
interest had they highlighted case fatality rates 
(CFRs) of illnesses such as HIV/AIDS, TB and 
malaria. Since, every population in the country 
allegedly has access to free life-saving treatment 
and care for these illnesses. Such data would have 
not only highlighted any decline on the severity of 
outcome associated with AIDS, TB and malaria, 
but would have also assessed the effectiveness of 
control and prevention measures targeting 
predictors of mortality related to these diseases 
(18, 16).  
In 1989, Greenberg and coworkers estimated 
at 21% the severity of outcome associated with 
malaria in the city of Kinshasa (6), whether or not 
this rate has declined is still unknown. Though 
works by Tshikuka and collaborators (17) in this 
same city estimated CFRs of HIV co-infections 
with TB and malaria, CFRs associated with each 
specific illness and/or major causes of hospital 
admission were not examined. This study 
collected and analyzed data from hospitals in 
Kinshasa to address not only the missing 
information, but also factors associated with 
HIV/AIDS, TB and malaria mortality so as to 
provide stakeholders with enough evidence to 
tailor new policies and implementation strategies 
to address the burden of HIV/AIDS, TB, malaria 
and other infectious illnesses in developing 
countries. Our objectives were to: (i) identify 
major causes of hospital admissions in Kinshasa, 
DRC; (ii) estimate the severity of outcome or CFR 
associated with each such illness; (iii) compare 
CFRs associated to each illness between 
consecutive years; and (iv) to examine 
associations of mortality related to HIV/AIDS, TB 
and malaria with inpatients’ socio demographic 
and economic characteristics.  
 
SUBJECT AND METHODS 
 
The study was conducted in 14 hospitals in 
Kinshasa, DRC from 2007 to 2008 using a cross 
sectional retrospective survey and quantitative 
approach. At the time when the study was 
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conducted, the city had 66 hospitals. Admission 
fees of up to US$1,000 or more were charged by 
some hospitals, i.e., at Kinshasa Medical Center. 
Doctors often waited for inpatients or their 
relatives to bring money, medicines or even basic 
medical supplies such as bandages, before 
initiating treatment (16). Those who could not 
afford doctors’ requests received no treatment 
while in hospitals (16). Some hospitals had private 
wards where inpatients paid extra money to 
receive special care. Twenty three of the 66 
hospitals were selected at random; after a checkup 
of the quality of their record keeping, 9 were 
dropped and 14 were kept in the study.   
Hospital admission books, patient record 
files, hospital discharge books and mortuary 
record books were matched and data collected for 
2007 and 2008. From each inpatient, 21 data items 
were collected. They included the following: 
patient’s name, date of birth, gender, occupation, 
neighborhood of residence, municipality of 
residence, date of illness onset, admission date, the 
main causes of hospitalization (diagnosis 1, 2 and 
3) coded as by the international classification of 
diseases, ICD –10; whether or not patients stayed 
in a private ward, whether or not patient’s 
relatives brought money, medicine or medical 
supply requested by the doctor; admission fees 
paid, year patient was admitted, year patient was 
discharged from the hospital, whether patient was 
cured or dead upon discharge, whether patient was 
transferred to another facility; whether he/she 
escaped from hospital, name of the hospital, 
number of hospital beds, number of nurses, 
number of doctors. We recorded patients who 
afforded private wards and/or paid admission fees 
of US$1,000 or more as having a higher SES (20). 
Patients admitted twice or more times with the 
same condition within the same year were counted 
as single case for that year. Apart from data 
obtained from hospital records, no contact was 
made with respondents or surrogates to obtain 
additional information on patients. Information on 
the severity of illnesses at admission was missing 
from record books; hence, patients who died or 
were discharged after less than 24 hours of 
admission, as well as bodies brought to mortuaries 
simply because of death certificates were excluded 
from the analysis. Also, excluded from the study 
were patients hospitalized for reasons other than 
medical condition, i.e., birth.       
Double data entry was performed and 
assessment done using EpiData 3.1 (CDC, 
Atlanta, Georgia, USA); SPSS 16 (Gorinchem, 
Netherlands) in data analysis. The frequency 
distribution (%) of inpatients by cause of 
hospitalization was assessed for 2007 and 2008. 
CFR (%) of every illness was estimated as the 
ratio of the number of deaths associated with a 
particular illness over the number of inpatients 
admitted for that specific illness, times 100. We 
compared CFRs between 2007 and 2008 using 
Chi-Square analysis with Yates’ Correction. 
Associations of malaria, HIV/AIDS and TB-
related deaths with socio demographic and 
economic characteristics were investigated using 
three logistic regression sub-models (21): (i) sub-
model A with malaria-related deaths as dependent 
variable, (ii) sub-model B with HIV/AIDS-related 
deaths as dependent variable and, (iii) sub-model 
C with TB-related deaths as dependent variable. 
The following variables were investigated as 
potential predictors of mortality to compute for 
adjusted odds ratios (AOR) and their 95% 
confidence intervals as approximations of adjusted 
relative risks: inpatient SES, age, gender, area of 
residence, municipality of residence, month of 
illness onset and year of hospitalization. Numbers 
of hospital beds per doctor, the number of hospital 
beds per nurse and malnutrition among inpatients 
were investigated as potential confounders. As 
HIV concurrent infections were already discussed 
elsewhere (17), HIV inpatients co-infected with 
TB and/or malaria, were all included in the 
analysis as HIV/AIDS patients only. Redundancy 
and multicollinearity of covariates were checked 
using the tolerance/VIF diagnostic. All variables 
significant in the main effect models (as well as 
those suspected to have different relationships 
with the outcome variable depending on the third 
factor) were investigated in a series of interaction 
term. How well the models fit the data were 
estimated using the Hosmer-Lemeshow test of 
goodness of fit. The level of significance was set 
at P < 0.05. 
The School of Public Health Ethical Committees 
provides general oversight and ethical approval in 
DRC. This committee does not require a formal 
submission for ethical approval for the type of 
study presented herein. However, consent from 
hospital managements was obtained by confirming 





that the data will be used only for research 




Selected hospitals had a total capacity of 4,796 
beds and healthcare services were provided by 922 
doctors and 3,175 nurses. There were no records 
of ART, TB or malaria drug supply breakdowns in 
selected hospitals throughout the study period. 
Diagnostic tests used in all these hospitals were 
similar and met the national standard.  
Data came from 23,487 inpatients: 13,358 
(57%) from 2007 records and 10,129 (43%) from 
2008 records; 11,558 (49.2%) patients were male 
and 11,929 (50.8%) were female. The median age 
was 21 years (interquartile range: 3 – 37 years). 
The majority of inpatients, 18,806 (80.1%), 
recovered from their illnesses upon discharge, yet 
2,421 (10.3%) died in hospitals; 1,807 (7.7%) 
patients were transferred from one hospital to 
other facilities, while 453 (1.9%) near recovery 
patients escaped from hospitals before discharge. 
Only 19.5% of inpatients were considered as 
having HSES, while the rest, 80.5%, were 
categorized as having LSES. Data also showed 
that 49.2% inpatients lived in semi-urban areas 
and 50.8% lived in urban areas; only 10.9% of 
inpatients lived in rich neighborhoods.  
Data presented in Table 1 show the 
distribution pattern of inpatients by cause of 
hospitalization in 2007 and 2008: 37.4% of 
admissions were due to malaria alone during the 
two-year study period; 7.5% were due to acute 
respiratory infection (ARI), 5.8% to diarrhea, 
5.6% to TB, 5.5% to HIV/AIDS, 2.6% to traffic 
injuries (TI), 2.5% to malignancies, 2.2% to 
malnutrition, 1.7% to sexually transmitted 
diseases (STD), 1.4% to vaccine preventable 
diseases (VPD) and 27.7% of hospitalizations 
were due to other illnesses. 
 
Table 1: Distribution pattern (%) of inpatients by cause of hospitalization in 2007 and 2008 in 14 Kinshasa 
Hospitals, DRC 
 
Cause of Hospitalization Year of Hospitalization Total 
2007 2008 
 Case % Case % Case % 
Malaria 4916 36.8 3858 38.1 8774 37.4 
ARI 905 6.8 867 8.6 1772 7.5 
Diarrhea  679 5.1 688 6.8 1367 5.8 
TB 642 4.8 683 6.7 1325 5.6 
HIV/AIDS 651 4.9 651 6.4 1302 5.5 
TI 308 2.3 295 2.9 603 2.6 
Malignancies 339 2.5 253 2.5 592 2.5 
Malnutrition  216 1.6 309 3.1 525 2.2 
STD 207 1.5 183 1.8 390 1.7 
VPD 169 1.3 164 1.6 333 1.4 
Others  4326 32.4 2178 21.5 6504 27.7 
All Causes 13358 100 10129 100 23487 100 
Legend: ARI = acute respiratory infections; TB =Tuberculosis; HIV =human immunodeficiency virus; 
AIDS =acquired immunodeficiency syndrome; TI=traffic injuries; STD =sexually transmitted diseases; 
VPD = vaccine preventable diseases; others = all other diseases 
 
CFRs associated to each cause of admission are 
presented in Table 2. Significant (P < 0.05) 
increases are observed in malaria, HIV/AIDS, 
ARI, VPD and TB (P = 0.06) in 2008 compared to 
2007. Of all causes of hospitalization, 
malignancies have the highest CFR, while malaria 
has the lowest. 
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Table 2: Severity of outcomes or case fatality rates (CFR %) associated to major causes of hospitalization 





Year of Hospitalization  
Total 2007 2008 





 575/8774 6.6 
HIV/AIDS* 126/651 19.4
a
 165 651 25.3
b





 284/1772 16.0 







 252/1325 19.0 
Malignancy 110/339 32.4 74/253 29.2 184/592 31.1 
STD 41/207 19.8 35/183 19.1 76/390 19.5 
TI 31/308 10.1 31/295 10.5 62/603 10.3 





 44/333 13.2 




 330/6504 5.1 




 2421/23487 10.3 
Legend: *P < 0.05; 
ψ
borderline significance P = 0.06; ARI = acute respiratory infections; TB = Tuberculosis; HIV = 
human immunodeficiency virus; AIDS = acquired immunodeficiency syndrome; TI = traffic injuries; STD = sexually 
transmitted diseases; VPD = vaccine preventable diseases; others = all other conditions; 
®
different superscript letters 
within a row indicate significant difference (P < 0.05) 
 
Multivariate sub-models presented in Table 3 
reveal that patients hospitalized for malaria, HIV, 
and TB in 2008 were more likely to die from these 
diseases than patients hospitalized in 2007 with 
the same conditions. Results also indicate that 
LSES inpatients admitted for malaria, TB and 
HIV/AIDS were more likely to die than HSES 
inpatients admitted for the same diseases; resident 
of semi-urban areas were more likely to die from 
malaria than those from urban areas. Only 
HIV/AIDS or TB inpatients aged 0 –13 years old 
were less likely to die from these conditions 
compared to inpatients aged ≥50 years old. 
Inpatients aged 14 – 49 years old had the same 
risk of dying of HIV (P=0.44) or TB (P=0.36) as 




Outstanding findings in this study were that 
severities of outcomes associated with major 
illnesses in 2008 were relatively higher than in the 
previous year. In 2008 for instance, malaria CFR 
was 8.3% compared to 5.2% in 2007; HIV CFR 
was 25.3% compared to 19.4% in 2007; TB CFR 
was 20.9% compared to 17% in 2007. This clearly 
suggests that the quality of care provided to 
patients and control and prevention measures 
implemented in 2008 were less effective than in 
2007 (22). Yet, looking at resources allocated to 
the three diseases by the GFATM initiative alone 
(9), there was potential for decrease in CFRs of 
these illnesses each consecutive year (22). Our 
present study points to the contrary. Indeed, 
reports from Kinshasa Provincial Health Authority 
(19) also indicated substantial increase in malaria 
related mortality in 2008 than the previous years, 
thus lending support to our results, and at the same 
time, raising questions on factors responsible for 
such an increase.  
Our multivariate analysis to highlight factors 
associated with such mortality also revealed that 
inpatients hospitalized for HIV/AIDS, TB and 
malaria in 2008 were more likely to die than those 
hospitalized in 2007 for the same diseases; and 
that LSES inpatients admitted for malaria, TB or 
HIV/AIDS were more likely to die than HSES 
inpatients admitted for the same diseases. While 
on one hand these results lead to speculations that 
between 2007 and 2008 no progress was made in 
this city toward meeting GFATM objectives, they 
also suggest that in resource poor settings, the 
likelihood of dying from malaria, HIV/AIDS or 
TB is still associated with poverty (23), despite 
presumably free access to life-saving treatment 
and care for these diseases (10). 





Table 3: Socio-demographic and economic factors independently associated with malaria, HIV/AIDS, and 
TB-related deaths among inpatients in Hospitals in 2007 and 2008. 
 
Sub Model A 
Dependent Variable: Malaria-related Death (N = 8,774) 
 
 Proportion% Unadjusted Adjusted 
Independent Variables  OR 95%CI OR 95%CI 
Year: 2007 44.5 1  1  
          2008 55.5 1.64* 1.38 – 1.95 1.85* 1.55 – 2.19 
SES: Low 90.8 1  1  
         High 9.2 0.47* 0.36 – 0.63 0.29* 0.22 – 0.40 
AR: Semi urban 54.4 1  1  
        Urban 45.6 0.67* 0.56 – 0.80 0.49* 0.45 – 0.58 
Hosmer-Lemeshow test of goodness of fit ψP = 0.05 
Sub Model B 
Dependent Variable: HIV/AIDS-related Death (N = 1,302) 
 Proportion% Unadjusted Adjusted 
Independent Variables  OR 95%CI OR 95%CI 
Year: 2007 43.3 1  1  
          2008 56.7 1.42* 1.1 – 1.8  2.15* 1.61 – 2.85 
SES: Low 93.0 1  1  
         High 7.0 0.29* 0.18 – 0.46 0.20* 0.12 – 0.33 
Age group: ≥ 50 years 27.5 1  1  
                   0 – 13 years 9.6 0.23* 0.15 – 0.37 0.18* 0.11 – 0.30 
                   14 – 49 years 62.9 1.07 0.78 – 1.46 1.14 0.83 – 1.56 
Hosmer-Lemeshow test of goodness of fit P = 0.41 
 
Sub Model C 
Dependent Variable: TB-related Death (N = 1,325) 
 Proportion% Unadjusted Adjusted 
Independent Variables  OR 95%CI OR 95%CI 
Year: 2007 43.3 1  1  
          2008 56.7 1.29 0.98 – 1.7  1.32
ψ
 0.99 – 1.75 
SES: Low 91.3 1  1  
         High 8.7 0.41 0.26 –0.6) 0.33* 0.21 – 0.53 
Age group: ≥ 50 years 23.0 1  1  
                   0 – 13 years 9.1 0.23* 0.14 – 0.38 0.21* 0.12 – 0.35 
                   14 – 49 years 67.9 0.87 0.62 – 1.20 0.85 0.60 – 1.20 
Hosmer-Lemeshow test of goodness of fit P = 0.29 
Legend: Year = year of hospitalization; SES = socioeconomic status; age groups = (0 – 13 years old, 14 – 49 years 
old, ≥ 50 years old; reference group ≥ 50 years old); AR = area of residence (semi-urban area, urban area); *P < 0.05, 
ψ
borderline significance (P = 0.05) 
 
These findings are strongly supported by others 
(24, 25), even though they do not explain why 
LSES patients are more at risk of dying than 
HSES patients, seeing that both groups 
presumably had access to free life-saving 
treatment and care for TB and HIV/AIDS. If 
Wood et al (25) found LSES patients more at risk 
of dying from HIV/AIDS than HSES patients, it 
was quite normal because in their study, LSES 
patients were less likely to be prescribed Highly 
Active Antiretroviral Treatment (HAART). Where 
we conducted this study, HIV and TB drugs and 
care are meant to be totally free (9). Also, 
treatment of severe malaria is highly subsidized; 
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in which case, the difference in CFRs between the 
two groups cannot be justified.  
However, in resource poor settings like 
Kinshasa, where healthcare professionals struggle 
for their own survival and often request money, 
medicines and even basic medical supplies from 
inpatients or their relatives before initiating 
treatment (16), it is hard to believe that there were 
no hurdles for LSES inpatients to access free life-
saving ART or TB drugs and care (16). In 
addition, the fact that inpatients’ food rations had 
to come from their families outside hospitals, 
differences in diet might also have had varying 
impacts on patients’ response to treatment (26).  
Other key findings in this study were that: 
inpatients from semi-urban areas were more likely 
to die from malaria compared to those from urban 
areas. This lends support to existing data (15). 
While inpatients aged 0 –13 years were less likely 
to die from HIV/AIDS and TB compared to ≥ 50 
years old reference group, inpatients aged 14 – 49 
years had the same risk of dying from HIV/AIDS 
(P = 0.44) and TB (P = 0.36) as those aged ≥ 50 
years old likely because of uncontrolled 
underlying medical conditions (27).    
Our non-inclusion of underlying medical 
conditions, i.e., diabetes mellitus, and renal failure 
(27), in the analysis as potential confounders 
might be a limiting factor. Other limiting factors 
might come from the use of hospital data to study 
mortality (28) and case fatality in a developing 
country setting where not every sick person 
attends hospitals, and burials often occur without 
the knowledge of the cause of death which might 
have underestimated outcomes. Hospital data in 
developing countries are often of poor quality and 
differences among groups may come from 
variables other than those under study, i.e., 
epidemics, improvement in recording system, etc. 
Nevertheless, data that are regularly generated in 
hospitals have been effectively used for 
epidemiological purposes (6, 27) as they are 
inexpensive and readily available. And, in 
developing countries like DRC where health data 
are often lacking, hospital data can provide good 
evidence for planning and decision making if they 
are properly collected and processed (6). In this 
work, we meticulously addressed these issues; of 
the 23 hospitals that were preliminary selected, 9 
were dropped for poor record keeping. Patients 
whose data were missing or could not be matched 
between different sources within the same hospital 
were excluded from the study. Based on this, we 
are doubtful that factors other than those discussed 
here explain the results.  
In short, findings in this study indicate that 
while the impact of health programs on indicators 
greatly depends on availability and sustainability 
of funds, these alone might not be enough in 
resource poor developing countries. Other factors, 
i.e., population SES also need to be addressed 
before needed changes may occur. It is hoped that 
this discussion will stimulate research for more 
evidence on socioeconomic factors association 
with population health indicators as a base for 
policy and decision making in a global effort to 
tailor new approaches to address the burden of 
diseases in developing countries. 
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